- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04090723
Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum
November 24, 2025 updated by: Johns Hopkins University
Unhealthy alcohol use among women with and at risk for HIV can interrupt critical steps in the HIV prevention and care continuum, is associated with HIV transmission risk behaviors, and contributes to health disparities.
Thus it is critical to accurately identify alcohol use and implement alcohol interventions among women with and at risk for HIV to optimize health outcomes.
The proposed pilot study will examine the implementation and effects of a computer delivered brief alcohol intervention with peer navigation/Community Health Worker compared to usual care on alcohol use, linkage to health services, and uptake of HIV prevention practices.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Women account for 1 in 4 people living with HIV (PLWH) in the United States, and while African American (AA) women comprise only 14% of the US female population, African American women account for greater than 60% of women living with HIV (WLWH).
Unhealthy alcohol use interrupts critical steps in the HIV prevention and care continuum (HPACC) and thus contributes to significant health disparities among at-risk and WLWH.
The investigators have developed theory-based, in-person and computer-delivered brief interventions (CBI) for at risk and WLWH with alcohol use, demonstrating drinking reduction.
However behavioral and structural barriers to optimal uptake of alcohol interventions and engagement in the HPACC remain, including mental health comorbidity and low knowledge, access, and use of HIV prevention practices such as HIV pre-exposure prophylaxis (PrEP).
The goals of this proposal are two-fold: 1) to build on the investigators' current community partnerships to determine how to optimally implement evidence based alcohol treatment for at risk and WLWH in Baltimore, and 2) to determine whether the addition of information, motivational and peer navigator/Community Health Worker support related to comorbid mental health, and HIV prevention practices can enhance CBI and improve alcohol and HPACC outcomes among at risk and WLWH.
To achieve these goals the investigators will use a Community Based Participatory Research (CBPR) approach, engaging patient and community stakeholders during all aspects of study development, and community pilot testing.
In collaboration with the investigators' Community Advisory Board (CAB), the investigators will: 1) adapt the investigators' current CBI to address gaps in the HIV prevention and care continuum (CBI-CC).
The investigators will conduct focus groups with both at risk and WLWH to tailor intervention manuals.
2) The investigators will conduct a pilot study of CBI-CC and peer navigation among 30 at-risk or WLWH with unhealthy alcohol use.
The investigators hypothesize that the CBI-CC will result in reduction in drinking and heavy drinking days, increase linkage to substance use, and mental health services and HIV pre exposure prophylaxis (PrEP), and increase use of HIV prevention practices including condoms and PrEP.
Through this U34 planning grant the investigators will partner with key stakeholders in the community to build capacity to deliver effective, evidence-based interventions at the nexus of alcohol and HIV for at risk and WLWH with alcohol misuse, and improve engagement in the HIV prevention and care continuum.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- At risk and Women with HIV ≥18 years
- Alcohol misuse, defined as >7 standard drinks per week or > 3 drinks per occasion in the last three months or AUDIT-C ≥3
- Able to understand English
- Able to read at a 5th grade level.
Additional inclusion criteria for at risk women:
- sex under the influence of alcohol or
- exchanging sex for money or other resources or
- unprotected vaginal or anal sex or illicit drug use in the last 12 months
Exclusion Criteria:
- Pregnant (will be referred immediately to alcohol, mental health, substance use treatment as needed)
- Non-English speaking
- Unable to receive text messages
- Actively psychotic, or otherwise not able to participate in the computer delivered brief intervention.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computer-delivered brief alcohol intervention (CBI-CC)
Participants will be offered only the Computer-delivered brief alcohol intervention with peer navigation from beginning of study to the end.
|
Computer delivered brief alcohol intervention enhanced with information of HIV infection, HIV risk, and comorbid mental health disorders
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Feasibility as assessed by a 4-item scale
Time Frame: 3 months
|
Feasibility of the Intervention will be assessed by the Mean/Median score on a 4 item scale that measures the extent to which the new treatment, or an innovation, can be successfully used or carried out within a given agency or setting.
Score ranges from 5-20 on the 4 item scale.
Higher score means greater feasibility.
|
3 months
|
|
Intervention Acceptability as assessed by a 4-item scale
Time Frame: 3 months
|
Acceptability of the Intervention will be assessed by the Mean/Median score on a 4 item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory.
Score ranges from 5-20 on the 4 item scale.
Higher score means greater acceptability.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants linked to services
Time Frame: 3 months
|
Linkage to mental health, substance use, HIV pre-exposure prophylaxis or HIV clinical services.
|
3 months
|
|
Number of participants with pre-exposure prophylaxis (PrEP) or condom uptake
Time Frame: 3 months
|
Uptake of HIV pre-exposure prophylaxis or condoms by participants.
|
3 months
|
|
Number of drinking days
Time Frame: At 3 months
|
Number of drinking days over past 30 days
|
At 3 months
|
|
Number of heavy drinking days
Time Frame: At 3 months
|
Number of heavy drinking days over past 30 days
|
At 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of condom-less sex episodes
Time Frame: 3 months
|
This will be counted to assess sexual risk behavior.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Geetanjali Chander, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2021
Primary Completion (Actual)
January 25, 2024
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
September 12, 2019
First Submitted That Met QC Criteria
September 12, 2019
First Posted (Actual)
September 16, 2019
Study Record Updates
Last Update Posted (Actual)
December 1, 2025
Last Update Submitted That Met QC Criteria
November 24, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00175899
- U34AA026220 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol; Harmful Use
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
University of Massachusetts, WorcesterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful UseUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking | Harmful; Use, AlcoholUnited States
-
Boston University Charles River CampusNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful Use | Sex, UnsafeUnited States
-
KU LeuvenUnknownHarmful; Use, Alcohol | Hazardous; Use, Alcohol
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
Sykehuset i Vestfold HFSykehuset Innlandet HF; University Hospital, Akershus; Trondheim University Hospital and other collaboratorsActive, not recruitingHarmful Alcohol UseNorway
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
Daniela Romero ReyesUniversidad Nacional de Educación a DistanciaCompletedAlcohol; Harmful UseMexico
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Enrolling by invitationAlcohol Drinking | Alcohol; Harmful UseUnited States
Clinical Trials on CBI-CC with peer navigation
-
University of California, Los AngelesCompleted
-
University of California, San FranciscoNational Institutes of Health (NIH); ANOVA Health InstituteCompleted
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)Completed
-
Montefiore Medical CenterCenters for Disease Control and PreventionCompletedHIV-1-infection | Pre-exposure ProphylaxisUnited States
-
University of Colorado, DenverNational Institute of Mental Health (NIMH); University of Pittsburgh; University... and other collaboratorsRecruitingMental Health | Family Health | Mental Disorder, ChildUnited States
-
Michigan State UniversityBrown UniversityCompletedIndividuals With Serious Mental Illness Leaving JailsUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPrEP | HIV Prevention | Women | Intimate Partner Violence (IPV)United States
-
University Health Network, TorontoCanadian Cancer Society (CCS); Young Adult Cancer CanadaRecruitingSarcoma | Lymphoma | Breast Cancer | Testicular CancerCanada
-
CrescentCareRecruiting
-
University of MichiganCompletedGlucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus | Endocrine System DiseasesUnited States